Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 13, 2007, Pages 1108-1115

  Yilmaz, Bayram ^a,b   Ssempebwa, John ^b   Mackerer, Carl R ^c   Arcaro, Kathleen F ^b,d   Carpenter, David O ^b,e  

^a YEDITEPE UNIVERSITY   (Turkey)

^b UNIVERSITY AT ALBANY   (United States)

^c C and C Consulting in Toxicology   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; DIHYDROXYRHODAMINE 123; FLUORESCENT DYE; POLYCYCLIC AROMATIC COMPOUND; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CULTURE; CELL STRAIN MCF 7; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; OXIDATIVE STRESS; PETROLEUM; POLYCYCLIC HYDROCARBONS, AROMATIC; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 34250210729     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701208545     Document Type: Article

References (34)

1. Ambrosone, C. B. 2000. Oxidants and anti-oxidants in breast cancer. Antioxid. Redox. Signal. 2:903-917.
2. Arcaro, K. F., Gierthy, J. F., and Mackerer, C. R. 2001. Antiestrogenicity of clarified slurry oil and two crude oils in human breast-cancer cell assay. J. Toxicol. Environ. Health A 62:505-521.
3. Boffetta, P., Jourenkova, N., and Gustavsson, P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472.
4. Brody, J. G., and Rudel, R. A. 2003. Environmental pollutants and breast cancer. Environ. Health Perspect. 111:1007-1019.
5. Burczynski, M. E., Lin, H. K., and Penning, T. M. 1999. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: Implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 59:607-614.
6. Calaf, G., and Russo, J. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483-492.
7. Chaloupka, K., Harper, N., Krishnan, V., Santostefano, M., Rodriguez, L. V., and Safe, S. 1993. Synergistic activity of polynuclear aromatic hydrocarbon mixtures as aryl hydrocarbon (Ah) receptor agonists. Chem. Biol. Interact. 89:141-158.
8. Collins, J. F., Brown, J. P., Alexeeff, G. V., and Salmon, A. G. 1998. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol. 28:45-54.
9. Damianaki, A., Bakogeorgou, E., Kampa, M., Notas, G., Hatzoglou, A., Panagiotou, S., Gemetzi, C., Kouroumalis, E., Martin, P. M., and Castanas, E. 2000. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem. 78:429-441.
10. Eldridge, S. R., Gould, M. N., and Butterworth, B. E. 1992. Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res. 52:5617-5621.
11. Eray, M., Matto, M., Kaartinen, M., Andersson, L., and Pelkonen, J. 2001. Flow cytometric analysis of apoptotic subpopulations with a combination of annexin V-FITC, propidium iodide, and SYTO 17. Cytometry 43:134-142.
12. Feuston, M. H., Hamilton, C., Schreiner, C. A., and Mackerer, C. R. 1997. Developmental toxicity of dermally applied crude oils in rats. J. Toxicol. Environ. Health 52:79-93.
13. Feuston, M. H., and Mackerer, C.R. 1996. Developmental toxicity of clarified slurry oil, syntower bottoms and distillate aromatic extract administered as a single oral dose to pregnant rats. J. Toxicol. Environ. Health 49:45-66.
14. Iwanari, M., Nakajima, M., Kizu, R., Hayakawa, K., and Yokoi, T. 2002. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: Chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 76:287-298.
15. Jeffy, B. D., Chirnomas, R. B., and Romagnolo, D. F. 2002. Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors. Environ. Mol. Mutagen. 39:235-244.
16. Kondraganti, S. R., Fernandez-Saluguero, P., Gonzalez, F. J., Ramos, K. S., Jiang, W., Moorthy, B. 2003. Polycyclic aromatic hydrocarbon-inducible DNA adducts: Evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int. J. Cancer. 103:5-11.
17. LaGoy, P. K., and Quirk, T.C. 1994. Establishing generic remediation goals for the polycyclic aromatic hydrocarbons: critical issues. Environ. Health Perspect. 102:348-352.
18. Mastrangelo, G., Fadda, E., and Marzia, V. 1996. Polycyclic aromatic hydrocarbons and cancer in man. Environ. Health Perspect. 104:1166-1170.
19. Mattanovich, D., and Borth, N. 2006. Applications of cell sorting in biotechnology. Microb. Cell Fact. 5:1-12.
20. Miles, A. M., Bohle, D. S., Glassbrenner, P. A., Hansert, B., Wink, D. A., and Grisham, M. B. 1996. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:40-47.
21. Palackal, N. T., Burczynski, M. E., Harvey, R. G., and Penning, T. M. 2001. The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: Potential role in polycyclic aromatic hydrocarbon activation. Biochemistry 40:10901-10910.
22. Penning, T. M., Burczynski, M. E., Jez, J. M., Hung, C.-F., Lin, H.-K., Ma, H., Moore, M., Palackal, N., and Ratnam, K. 2001. Human 3a-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the activation and formation of male and female sex hormones. Biochem. J. 351:67-77.
23. Penning, T. M., Ohnishi, S. T., Ohnishi, T., and Harvey, R. G. 1996. Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9:84-92.
24. Phillips, D. H. 1983. Fifty years of benzo(a)pyrene. Nature 303:468-472.
25. Rogan, E. G., Devanesan, P. D., Ramakrishna, N. V., Higginbotham, S., Padmavathi, N. S., Chapman, K., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. 1993. Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6:356-363.
26. Rothe, G., and Valet, G. 1994. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol. 233:539-548.
27. 2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200.
28. Rundle, A., Tang, D., Hibshoosh, H., Estabrook, A., Schnabel, F., Cao, W., Grumet, S., and Perera, F. P. 2000. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21:1281-1289.
29. Shih, H. A., Nathanson, K. L., Seal, S., Collins, N., Stratton, M. R., Rebbeck, T. R., and Weber, B. L. 2000. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clin. Cancer Res. 6:4259-4264.
30. 2 production in human epidermoid carcinoma cells by benzo[a]pyrene and ultraviolet A radiation. Toxicol. Appl. Pharmacol. 188:104-109.
31. Tang, Y., Donnelly, K. C., Tiffany-Castiglioni, E., and Mumtaz, M. M. 2003. Neurotoxicity of polycyclic aromatic hydrocarbons and simple chemical mixtures. J. Toxicol. Environ. Health A 66:919-940.
32. Tolbert, P. E. 1997. Oils and cancer. Cancer Cause Control 8:386-405.
33. Tsuruda, L., Hou, Y., and Penning, T. M. 2001. Stable expression of rat dihydrodiol dehydrogenase (AKR1C9) in human breast MCF-7 cells results in the formation of PAH-o-quinones and enzyme mediated cell death. Chem. Res. Toxicol. 14:856-862.
34. Yu, D., Berlin, J. A., Penning, T. M., and Field, J. 2002. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem. Res. Toxicol. 15:832-842.